European Commission publishes comprehensive pharma package
This article was originally published in SRA
Executive Summary
The European Commission has published a “pharmaceutical package” of measures intended to improve the provision of drug information to patients, tighten up the rules on pharmacovigilance and tackle the growing problem of counterfeit medicines1. The draft legislative proposals were published on 10 December.